Targeting the centrosome and polo-like kinase 4 in osteosarcoma
Author:
Affiliation:
1. Department of Medical Oncology, St. James Hospital, Dublin, Ireland
2. School of Medicine, Trinity College Dublin, Dublin, Ireland
3. Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Link
http://academic.oup.com/carcin/article-pdf/40/4/493/28788293/bgy175.pdf
Reference59 articles.
1. Centrosome amplification is sufficient to promote spontaneous tumorigenesis in mammals;Levine;Dev. Cell,2017
2. The PIDDosome activates p53 in response to supernumerary centrosomes;Fava;Genes Dev.,2017
3. Centrosome duplication: of rules and licenses;Nigg;Trends Cell Biol.,2007
4. Centrosome amplification and cancer: a question of sufficiency;Raff;Dev. Cell,2017
5. Centrosome biogenesis and function: centrosomics brings new understanding;Bettencourt-Dias;Nat. Rev. Mol. Cell Biol.,2007
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, and biological evaluation of novel pyrimidin-2-amine derivatives as potent PLK4 inhibitors;RSC Medicinal Chemistry;2023
2. Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review;Mini-Reviews in Medicinal Chemistry;2023-01
3. Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor;European Journal of Medicinal Chemistry;2022-12
4. Design, synthesis, and biological evaluation of a potent PLK4 inhibitor WY29 with 1 H ‐pyrazolo[3,4‐ d ]pyrimidine scaffold;Archiv der Pharmazie;2022-11-28
5. Repair of Spinal Cord Injury by Inhibition of PLK4 Expression Through Local Delivery of siRNA-Loaded Nanoparticles;Journal of Molecular Neuroscience;2021-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3